Programmed Death-ligand 1 Expression With Clone 22C3 in Non-small Cell Lung Cancer: A Single Institution Experience.

Maiko TakedaTakahiko KasaiMaiko NaitoAkihiro TamiyaYoshihiko TaniguchiNobuhiko SaijoYoko NaokiKyoichi OkishioShigeki ShimizuKensuke KojimaAkihiro NagoyaTetsuki SakamotoTomoki UtsumiHyung-Eun YoonAkihide MatsumuraShinji Atagi

Published in: Clinical Medicine Insights. Oncology (2019)

The rate of 22C3-PD-L1 expression of NSCLC detected in this study was similar to the frequencies of the previous reports, although the ratio of expression case decreased when using old paraffin blocks.

Keyphrases

poor prognosis
small cell lung cancer
binding protein
long non coding rna
emergency department
advanced non small cell lung cancer
adverse drug